Wikipedia:Articles for deletion/Aderis Pharmaceuticals


 * The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review).  No further edits should be made to this page.

The result was redirect to Rotigotine. ✗ plicit  14:23, 20 April 2022 (UTC)

Aderis Pharmaceuticals

 * – ( View AfD View log | edits since nomination)

Fails General Notability. I've been looking at potential supporting material for this organisation, but have not found sufficient material, in particular content where the company is the primary focus, to support the General Notability guideline. It pains me, as I do prefer to keep organizations of all types in the encyclopedia, but I believe this article should be lain to rest. Thank you for reviewing and providing your input. User:Ceyockey ( talk to me ) 12:14, 13 April 2022 (UTC)
 * Note: This discussion has been included in the list of Companies-related deletion discussions. AllyD (talk) 14:22, 13 April 2022 (UTC)
 * Note: This discussion has been included in the deletion sorting lists for the following topics: Health and fitness and Medicine.  CAPTAIN RAJU (T) 14:29, 13 April 2022 (UTC)
 * Note: This discussion has been included in the list of Massachusetts-related deletion discussions.  CAPTAIN RAJU (T) 14:30, 13 April 2022 (UTC)
 * Delete: The nominator added various pieces of coverage before this AfD, but, as is said above, they fall short of demonstrating notability for the company. Searches for Aderis Pharmaceuticals and the former "Discovery Therapeutics" find little better than passing mentions, and coverage of financial issues (up to this in 2005) which are insufficient for WP:CORPDEPTH. I am not seeing evidence that the company met the WP:NCORP notability criteria. AllyD (talk) 14:35, 13 April 2022 (UTC)
 * Redirect: to Rotigotine -- it seems the company's only claim to quasi-fame.   Ravenswing     16:31, 13 April 2022 (UTC)
 * Redirect to Rotigotine. Company has no independent notability.— rsjaffe 🗣️ 18:12, 13 April 2022 (UTC)
 * Comment from nominator&mdash;I do think that redirection is a reasonable outcome. --User:Ceyockey ( talk to me ) 13:24, 15 April 2022 (UTC)


 * The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.